Nuclear Medicine · Acibadem Maslak Hospital, İstanbul Assoc. Prof. Özge Vural Topuz, MD
✓ Medically verified profileAssoc. Prof. Özge Vural Topuz, MD
Assoc. Prof. Özge Vural Topuz, MD is a Nuclear Medicine specialist at Acibadem Maslak Hospital in İstanbul. Her areas of expertise include PET, SPECT, scintigraphy, brain scintigraphy, myocardial perfusion scintigraphy and radioiodine treatment, with published research on PET imaging in breast, colorectal, endometrial and prostate cancer. She communicates in Turkish and English and offers video consultation.
Accepting international patientsAbout Assoc. Prof. Özge Vural Topuz, MD
Assoc. Prof. Özge Vural Topuz, MD is a Nuclear Medicine specialist at Acibadem Maslak Hospital in İstanbul, where she practices within the Nuclear Medicine unit. She has more than 20 years in medicine. Her work centers on diagnostic nuclear medicine imaging, including PET, SPECT and scintigraphy, together with radioiodine treatment.
Dr. Topuz graduated from İstanbul Bilim University Faculty of Medicine in 2006 and completed her Nuclear Medicine specialty training at İstanbul University Cerrahpaşa Faculty of Medicine in 2011. From 2011 to 2020 she worked as a Nuclear Medicine Specialist at University of Health Sciences Okmeydanı Training and Research Hospital. Between 2020 and 2024 she practiced at Republic of Türkiye Ministry of Health Çam ve Sakura City Hospital. In 2024 she joined Health Sciences University, Hamidiye Faculty of Medicine Nuclear Medicine Department and Acıbadem Healthcare Services. Her published research includes studies on 18F-FDG PET/CT in locally advanced breast cancer, colorectal cancer and endometrial cancer, Ga-68 PSMA PET in prostate cancer, PSMA PET quantification and radiomic analysis, molecular imaging in GIST and primary peritoneal tumors, and case reports on differentiated thyroid carcinoma with liver metastases and on SPECT/CT findings.
Clinical focus
Dr. Topuz performs and interprets nuclear medicine imaging studies. Her areas of expertise include PET, SPECT and scintigraphy, as well as two specific scintigraphic examinations: brain scintigraphy and myocardial perfusion scintigraphy. These functional imaging methods are used to assess how organs and tissues are working and can support diagnosis, staging and treatment planning when used alongside other clinical and imaging information.
In addition to imaging, Dr. Topuz provides radioiodine treatment, a form of nuclear medicine therapy. Her research interests reflect her clinical work in oncologic imaging: her publications address 18F-FDG PET/CT parameters in patients with endometrial cancer and other tumors, and PSMA PET in patients with prostate cancer, including early response after 177Lu-PSMA radioligand therapy. Whether a given examination or treatment is appropriate depends on each patient’s individual clinical situation and is determined after review of the medical history and existing findings.
How Dr. Topuz works with international patients
Dr. Topuz communicates in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, arranges appointments and organizes the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the available options, including which nuclear medicine studies or treatments may be relevant. Video consultation is available for international patients who wish to discuss their case before deciding whether to travel.
What Dr. Topuz treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Conditions treated
- Brain scintigraphy
- Scintigraphy
Education, career and memberships
Education & training
Education
- 2011İstanbul University Cerrahpaşa Faculty of Medicine Nuclear Medicine
- 2006İstanbul Bilim University Faculty of Medicine
Career
Professional Experience
- 2024Acıbadem Healthcare Services
- 2024Health Sciences University, Hamidiye Faculty of Medicine Nuclear Medicine Department
- 2020–2024Republic of Türkiye Ministry of Health Çam ve Sakura City Hospital
- 2011–2020University of Health Sciences Okmeydanı Training and Research Hospital / Nuclear Medicine Specialist
Selected publications
Selected Publications
- Can post neoadjuvantchemotherapy 18F-FDG PET/CT predict residual cancer burden in locally advanced breast cancer? Medecine Nucleaire,2024;48(3),141-149. O.Vural Topuz, TS Akkurt, GU Erdem, E M Kaya, M Kaya, B EAkkaş.
- Molecular Imaging in GIST and Primary Peritoneal Tumors Nucl Med Semin. 2024 Jul;10(2):159-169. doi:10.4274/nts.galenos.2024.0013. ? Topuz ÖV.
- Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT. Nuklearmedizin. 2024;63:221-223. Vural Topuz O, Bagbudar S.
- Baseline Ga-68 PSMA PET-Derived Primary Tumor Parameters in Patients with Prostate Cancer and Their Association with Clinical Risk Stratification and Clinicopathologic Features. World Journal of Nuclear Medicine (2024) Topuz Özge Vural and Ayşegül Aksu
- A different perspective on 18F-FDG PET radiomics in colorectal cancer patients: The relationship between intra & peritumoral analysis and pathological findings. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023;42:359-366. Vural Topuz Ö, Aksu A, Yılmaz Özgüven MB
- A Rare Case of Differentiated Thyroid Carcinoma with Liver Metastases. Indian Journal of Nuclear Medicine, 2022;37:186-188. Topuz Özge Vural, Erhan S. S., Erinç S. R. & Tamam, M. Ö.
- The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Patholo Mol Imaging Radionucl Ther. 2022;31:16-22. Vural Topuz Ö, Aksu A, Erinç SR, Tokgözoğlu N, Tamam MÖ.
- Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses. Ann Nucl Med. 2022;36:310-318. Aksu A, Vural Topuz Ö, Yılmaz G, Çapa Kaya G, Yılmaz B.
- Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters Nucl Med Commun. 2022;10.1097. Aksu A, Vural Topuz Ö, Yilmaz B, Karahan Sen NP, Acar E, Çapa Kaya G.
- A case of soft tissue hematoma detected incidentally on 99m TC-labeled RBC gastrointestinal bleeding SPECT/CT. Technetium-99m-labeled RBC gastrointestinal Ulus Trauma Emergency Surg. 2022;28:113-115. Erinç R, Vural Topuz Ö, Tamam MÖ
